Look at 2023丨Li Yishu of Boya Life: Under the healthy China strategy, accelerate the launch of innovative products
Standing at the end of 2022 and looking at 2023, entrepreneurs, as an important force in the Chinese economy, how do you view the current Chinese economic policy and what are your expectations for the future of the Chinese economy? The Beijing News Shell Finance invited more than 100 entrepreneurs from all walks of life to complete their thoughts on the new year through questionnaires and explore the new driving force of China’s economic growth.
Shell Finance interviewed Li Yishu, Chairman and CEO of Boya Life.
Li Yishu, Chairman and CEO of Boya Life.Picture/provided by the interviewee
Shell Finance:What are your “small goals” for you and your business in the coming year?
Li Yishu:In 2023, the small goal of Boya Life is to innovate and develop and seek to break through.
The first is to achieve a qualitative leap in the business side, continuously improve and enhance the service model and service capabilities, and provide users with better and more considerate services through the “precision service” digital customer platform; the second is in the “medical equipment”, ” The three directions of “life bank” and “cell medicine” will expand the whole industry chain, focus on the development of bioscience technology, and deeply cultivate the innovation and industrialization of cell technology; the third is to closely follow the national “Healthy China” strategic goal and join hands with government, industry, academia and research to jointly promote The development of the cell technology industry will enhance the ability to source scientific and technological innovation, jointly promote clinical research and transformation applications, accelerate the process of launching innovative products such as immune cells and stem cells, and strive to improve national health.
Shell Finance:What help and support, or good news, would you like to have in order to achieve this goal?
Li Yishu:First of all, it is hoped that the government will pay more attention to the development of life sciences, especially to strengthen policy support for the cell technology industry, refine the industry regulatory system, create a good policy environment for the new pattern of industry development, and bring new innovations to the transformation and implementation of cell innovation technologies and products. opportunity.
We also hope that the state will encourage and support the business development, technological innovation and technological breakthroughs of private enterprises in the cell technology industry, including key technology research, clinical transformation research, research and development of upstream, midstream and downstream products, cell bank construction and operation, and innovation carrier construction, etc. Promote the improvement of the industrial chain and industrialization development in the field of cell technology.
We look forward to the further opening and improvement of cell therapy policies and regulations. Now we are even more hopeful that the epidemic will no longer affect logistics, transportation, cross-regional exchanges, and the normal operation of medical institutions. The entire industry may usher in new opportunities for development. I believe 2023 will be a better year.
Beijing News Shell Finance reporter Li Yunqi and Ding Shuang
Edit Xu Chao
Proofreading Liu Baoqing
